Detected ·
Caldera Therapeutics
$278M—
Caldera Therapeutics announced a merger with Synlogic alongside an upsized private placement expected to generate approximately $278M in gross proceeds to advance its lead bispecific antibody CLD-423 through Phase 2 trials.
- Website
- www.calderatx.com
- Amount
- $278 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-24 04:15:38 UTC
- Signal ID
- 22b587ef-03bf-4208-85b3-9c27213a8232
As the API returns it
{
"id": "22b587ef-03bf-4208-85b3-9c27213a8232",
"created_at": "2026-09-24T04:15:38.789029Z",
"company_name": "Caldera Therapeutics",
"company_website_url": "www.calderatx.com",
"company_linkedin_url": "https://www.linkedin.com/company/caldera-therapeutics",
"event_type": "funding",
"funding_amount": 278000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Caldera Therapeutics announced a merger with Synlogic alongside an upsized private placement expected to generate approximately $278M in gross proceeds to advance its lead bispecific antibody CLD-423 through Phase 2 trials.*"
}